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Abstract
Human immunodeficiency virus type 1 (HIV-1)-associated dementia (HAD) usually occurs late in the course of HIV-1
infection and the mechanisms underlying HAD pathogenesis are not well understood. Accumulating evidence indicates that
neuronal voltage-gated potassium (Kv) channels play an important role in memory processes and acquired neuronal
channelopathies in HAD. To examine whether Kv channels are involved in HIV-1-associated neuronal injury, we studied the
effects of HIV-1 glycoprotein 120 (gp120) on outward K+ currents in rat cortical neuronal cultures using whole-cell patch
techniques. Exposure of cortical neurons to gp120 produced a dose-dependent enhancement of A-type transient outward
K+ currents (IA). The gp120-induced increase of IA was attenuated by T140, a specific antagonist for chemokine receptor
CXCR4, suggesting gp120 enhancement of neuronal IA via CXCR4. Pretreatment of neuronal cultures with a protein kinase C
(PKC) inhibitor, GF109203X, inhibited the gp120-induced increase of IA. Biological significance of gp120 enhancement of IA
was demonstrated by experimental results showing that gp120-induced neuronal apoptosis, as detected by terminal
deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay and caspase-3 staining, was attenuated by either an IA
blocker 4-aminopyridine or a specific CXCR4 antagonist T140. Taken together, these results suggest that gp120 may induce
caspase-3 dependent neuronal apoptosis by enhancing IA via CXCR4-PKC signaling.
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Introduction
Human immunodeficiency virus type 1 (HIV-1)-infected
individuals often suffer from neurological complications such
as memory loss, mental slowing, and gait disturbance [1]. The
severity of such impairments can vary, ranging from asympto-
matic neurocognitive impairment, to mild neurocognitive disorder
and to HIV-associated dementia (HAD), which are now collec-
tively referred to as HIV-associated neurodegenerative disorders
(HAND) [2]. The mechanisms of neuronal injury in HAND,
including reduction of synaptic contacts [3], dendritic pruning [4],
and selective neuronal loss [5] and apoptosis [6], remain incom-
pletely understood. Current consensus holds that secreted soluble
factors such as cytokines, chemokines, excitatory amino acids,
nitric oxide, arachidonic acid and metabolites, and viral proteins,
diffuse within the central nervous system (CNS) to directly or
indirectly damage neurons [7,8]. In particular, the role of HIV-1
envelope glycoprotein 120 (gp120) in HAND neuropathology has
drawn considerable research attention.
In HIV-1-infected brain, gp120 may be shed off from virions or
secreted as a soluble substance by HIV-1-infected mononuclear
phagocytes. To model its effects in the CNS, gp120 was
introduced into neuronal cultures and found to induce neuronal
apoptosis [9,10] even at very low concentrations [11]. This in vitro
gp120-mediated apoptosis was then confirmed with ex vivo
organotypic hippocampal slice preparations [12], transgenic
over-expression of glial gp120 [13,14], and direct stereotactic
intracranial injection [15,16]. A number of researchers have
established that gp120-induced apoptosis can be prevented by
blocking or down-regulating the CXCR4 receptors [17,18,19],
indicating gp120 can induce apoptosis through the CXCR4.
While research into the apoptotic pathways downstream of gp120
binding continue, new insights into the process of apoptosis are
also being made, in particular with regard to the crucial role of
voltage-gated potassium (Kv) channels.
Across various cell types, the process of apoptosis is character-
ized by cell volume decreases, caspase activation, and DNA
fragmentation, with accumulating evidence demonstrating K+
homeostasis involvement in each stage [20,21]. Since the original
experiment by Shan Ping Yu, et al. [22] demonstrating K+
ionophore insertion was sufficient to initiate and sustain apoptosis
in neurons, this sequence has been observed with various neuronal
insults and accompanied by increased K+ channel current [23].
Furthermore, K+ channel blockade and high K+ medium have
been found to prevent apoptosis in cultured cortical neurons
[22,24,25], cerebellar granule neurons [26,27], and rat hippo-
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gp120-mediated apoptosis and the essential nature of K+ channel
currents in the apoptotic process just described, here we test our
hypothesis that gp120 induces neuronal apoptosis via enhance-
ment of outward K+ currents. Our results demonstrated that
gp120 increased 4-aminopyridine (4-AP)-sensitive, A-type tran-
sient outward K+ currents (IA) leading to neuronal apoptosis in rat
cortical neuronal cultures.
Materials and Methods
Animal
Pregnant Sprague-Dawley rats were purchased from Jackson
Laboratory (Bar Harbor, Maine) and maintained under ethical
guidelines for care of laboratory animals at the University of
Nebraska Medical Center. All animal-use procedures were
reviewed and approved by the Institutional Animal Care and
Use Committee (IACUC) of University of Nebraska Medical
Center (IACUC # 00-062-07).
Primary cortical neuronal culture
Purified cortical neurons were prepared from rat embryos
described previously [29]. Briefly, female Sprague-Dawley rats
with 18–19 days of gestation were anesthetized and embryonic
pups were surgically removed. Cerebral cortices were harvested
and digested using 0.25% trypsin and 200 U deoxyribonuclease I
(Sigma-Aldrich, St. Louis, MO) in Hank’s Buffered Salt Solution
(HBSS) (Invitrogen, Carlsbad, CA) at 37uC for 15 min. After
washing in HBSS, tissue mixtures were centrifuged, decanted and
sequentially passed through a 100 mm- and 40 mm-mesh. The cells
were seeded at a density of 5610
5/dish (or well) in poly-D-lysine-
coated 35 mm culture dishes or 6 well plates and maintained in
neurobasal medium (Invitrogen) supplemented with 2% B-27
serum-free supplement, 1% penicillin/streptomycin, 0.2% fetal
bovine serum (FBS) and 0.25 mM L-glutamine (Invitrogen) for 7–
10 days. The purity of neural cells was determined by staining with
microtubule-associated protein-2 (MAP-2, a mature neuronal
marker) antibody (Millipore, Temecula, CA) and more than 90%
of MAP-2 positive cells were obtained.
Electrophysiology
Whole-cell patch recordings were performed in rat cortical
neuronal cultures in 35 mm tissue culture dishes on the stage of an
inverted Nikon microscope (TE 300) using an Axopatch 200B
amplifier (Molecular Devices, Sunnyvale, CA). Patch electrodes,
made from borosilicate glass micropipettes (WPI Inc. Sarasota, FL)
with a P-97 micropipette puller (Sutter Instruments, Novato, CA),
had tip resistance of 5.0–8.0 MV. The electrodes were advanced
towards cells by a Burleigh micromanipulator (PC-5000, EXFO,
Canada). After establishment of the whole-cell patch configura-
tion, the cells were allowed to stabilize for 3–5 min before tests.
The recorded cells were held at 260 mV during voltage clamping.
Whole-cell outward K
+ currents were induced by applying 300 ms
depolarizing steps from the holding potential of 260 mV to
240 mV in the first step, and then stepped to +60 mV in
increments of 10 mV. Junction potentials were corrected, serial
resistance was compensated and cell capacitance was partially (60–
70%) compensated. Current signals were filtered at 1 kHz and
digitized at 5 kHz using Digidata 1440A digitizer (Molecular
Devices). The current and voltage traces were displayed and
recorded in a computer using pCLAMP 10.2 data acquisition/
analysis system (Molecular Devices).
The pipette solution for voltage-clamp experiments contained
(in mM): 108.0 K2HPO4, 9.0 HEPES, 9.0 EGTA, 2.5 MgCl2,
14.0 creatine phosphate (Tris salt), 1.0 Mg-ATP, and 0.3 Tris-
GTP, buffered to pH 7.4 with KOH. The extracellular solution
contained (in mM): 150.0 NaCl, 4.0 KCl, 2.0 MgCl2, 2.0 CoCl2,
10.0 HEPES, 20 tetraethylammonium (TEA, Sigma-Aldrich) and
10 glucose, buffered to pH 7.4 with NaOH. In order to block
sodium channels, 0.3 mM tetrodotoxin (TTX; Tocris, Ellisville,
MO) was added. To block calcium-activated K
+ currents,
extracellular Ca
2+ was replaced with equimolar Co
2+ (2.0 mM)
[30]. Stock solutions of TEA (1.0 M), 4-AP (1.0 M, Sigma-
Aldrich), and TTX (0.2 mM) were prepared in deionized water
and either stored at 4uC (TEA and 4-AP) or in aliquots at 220uC
(TTX).
All experiments were done at room temperature (22–23uC).
The neuronal cells were identified by their triangular-shaped
morphology and their firing of action potentials in response to a
depolarizing current injection. Chemical reagents were applied
through incubation (2 h) in 95% CO2 and 5% O2 at 37uC. Data
were analyzed by Clampfit 10.2 (Molecular Devices). For each set
of experiments, the instantaneous outward currents generated by
voltage steps from 260 mV to +60 mV were measured and
analyzed.
TUNEL assays
Terminal deoxynucleotidyl transferase dUTP nick end labeling
(TUNEL) staining was performed to evaluate apoptotic neurons
by using in situ cell death detection kit, AP (Roche Applied Science,
Indianapolis, IN) according to the manufacturer’s instructions.
Briefly, rat cortical neurons grown on poly-D-lysine coated
coverslips at a density of 1610
5/well in 24 well plates were pre-
treated with CXCR4 blocker, T140 (50 nM, kindly provided by
Dr. Nobutaka Fujii, Graduate School of Pharmaceutical Sciences,
Kyoto University, Kyoto 606-8501, Japan) or Kv channel blocker
4-AP (5 mM) 30 min before addition of 500 pM gp120 (Im-
munoDiagnostics, Inc., Woburn, MA). After treatments of 24 h,
the neurons were fixed with 4% paraformaldehyde and permea-
bilized 0.1% Triton X-100 (Sigma) in 0.1% sodium citrate solution
for 2 min on ice. After wash, the cells were then incubated with
TUNEL reaction mixture containing terminal deoxynucleotidyl
transferase and fluorescein-labeled nucleotides at 37uC for 60 min.
After final wash, coverslips were mounted in ProLong Gold
antifade reagent (Molecular Probes, Eugene, OR) with 49,69-
diamidino-2-phenylindol (DAPI) and visualized by fluorescent
microscope using a620 objective. The TUNEL-positive cells were
analyzed by NIH ImageJ software and the percentage of TUNEL-
positive cells (green) was normalized to total DAPI-positive cells
from 12 microscopic fields.
Immunocytochemistry
Neurons growing on poly-D-lysine-coated coverslips were
treated with gp120 in the presence or absence of T140, 4-AP, or
as indicated. After 24 h treatments, neurons were fixed in 4%
paraformaldehyde and blocked in phosphate buffered saline (PBS)
containing10% normal goat serum and 0.1% Triton X-100 for
30 min at room temperature. Neurons were incubated with
primary antibody anti-caspase 3 (1:200 Cell Signaling Technology,
Beverly, CA) or mouse monoclonal anti-NeuN (1:100; Millipore)
diluted in blocking solution for 2 h, followed by application of
AlexaFluor 488 (1:500) and AlexaFluor 594 (1:500) secondary
antibody (Invitrogen) in PBS+10% HIGS for 1 h. The fluorescent
images were captured using Olympus DP70 camera and DP
Controller Ver. 2.1.1 software. The values of fluorescent intensity
were acquired using ImageJ software (National Institutes of
Health) and then normalized with cell numbers.
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All data were expressed as mean 6 SEM and graphed using
Origin 8.0 software (OriginLab, Northampton, MA) unless
otherwise indicated. Statistical analyses were performed by one-
way ANOVA analysis or by Student t tests. A minimum p value of
0.05 was estimated as the significance level for all tests.
Results
Expression of outward K
+ currents in cultured rat cortical
neurons
Outward K
+ currents generated by voltage steps (Fig. 1A) were
recorded in rat cortical neurons after 7–10 days in culture. The
average peak current amplitude, generated by a voltage step from
260 mv to +60 mV, was 3541.96369.5 pA (Fig. 1B, n=8).
Addition of TEA (20 mM) to the bath solution reduced the peak
current to 2940.66383.5 pA (Fig. 1C, n=8), producing a
reduction of ,17% on peak current. The peak current was
further reduced to 905.36110.8 pA (Fig. 1D, n=8) by addition of
4-AP (5 mM) to the bath solution, resulting in a reduction of
,69% on the remaining peak current. The 4-AP-sensitive
outward K
+ currents were isolated by subtraction of the currents
recorded in the presence of both TEA and 4-AP from those
recorded in the presence TEA alone (Fig. 1E). Thus, the reduction
on peak current produced by 4-AP was ,58% when measured at
the voltage step of +60 mV.
Enhancement of neuronal IA by gp120
It is well-known that gp120 induces neuronal apoptosis [8] and
that enhancement of outward K
+ currents is believed to be an
essential pathway in programmed cell death [22,24,25]. To
examine whether gp120 induces neuronal apoptosis via increasing
IA, we first tested the effects of gp120 on IA in primary rat cortical
neuronal cultures. The 4-AP-sensitive IA and the 4-AP-insensitive
delayed rectifier like outward K
+ currents (IK) were recorded by
addition of TEA (20 mM) and 4-AP (5 mM) to the extracellular
solution, respectively. Incubation of rat cortical neurons with
gp120 (200 pM) for 2 h produced an enhancement of IA, with
an average instantaneous current density of 89.263.4 pA/pF
(n=115). In comparison with the current density of 78.762.6 pA/
pF (n=128) recorded in control neurons (without gp120
incubation), the difference was statistically significant (Fig. 2,
p,0.05). In contrast, the IK density recorded in neurons with and
without incubation with gp120 were 77.464.0 pA/pF (n=35) and
76.864.6 pA/pF (n=30), respectively. The difference was not
statistically significant (Fig. 2, p.0.05). These results indicate that
gp120 differentially enhances IA in cultured rat cortical neurons.
The enhancement of IA induced by gp120 was dose-dependent,
with average current densities of 89.263.4 pA/pF (n=115),
102.664.5 pA/pF (n=63), 115.365.0 pA/pF (n=57) when
neuronal cells were incubated with gp120 at concentrations of
200, 400 and 800 pM, respectively. The differences are statistically
significant (p,0.01), demonstrating an enhancement of IA by
gp120 (Fig. 3).
gp120 increases IA via CXCR4
C-X-C chemokine receptor type 4 (CXCR-4), a co-receptor for
HIV-1 infection, is expressed in the brain in a variety of cell types
including neurons [8,31,32]. Studies have shown that gp120
induces neuronal injury via CXCR4 [17,33]. To assess whether
gp120-induced enhancement of IA is mediated through activation
of neuronal CXCR4, we studied the effects of T140, a specific
CXCR4 receptor antagonist [34,35], on its blockade of gp120-
induced enhancement of IA. As shown in Fig. 4, incubation of
cortical neurons with gp120 (200 pM) increased the IA density by
33.4%, from 78.762.6 pA/pF (n=128) to 89.263.4 pA/pF
(n=115). Addition of T140 (50 nM) to the incubation medium
blocked gp120 enhancement of the IA, with an average current
density of 77.462.5 pA/pF (n=70). In comparison with the
gp120-induced enhancement, the difference is statistically signif-
icant (p,0.05), suggesting gp120 increase of neuronal IA via
CXCR4. Application of T140 alone had no apparent effect on
neuronal IA (Fig. 4).
Involvement of PKC signaling in gp120-mediated
increase of IA
As an extracellular toxic molecule, gp120 represents one of the
many exogenous signals that must be integrated by neurons. The
neurons accomplish this through evolutionarily conserved signal-
ing cascades, often comprised of reversibly modifiable kinases such
as the protein kinase C (PKC) family of isozymes [36]. PKC can
be activated by G-protein coupled receptors such as CXCR4
through production of its direct activator diacylglycerol (DAG) and
can have either pro- or anti-apoptotic effects depending on the
Figure 1. Expression of outward K
+ currents in cultured rat
cortical neurons. Whole-cell outward K
+ currents (B) was induced by
voltage steps (300 ms in duration) from the holding potential of
260 mV to 240 mV in the first step, and then stepped to +60 mV in
increments of 10 mV as shown at the top (A) (This voltage protocol was
used throughout this study). Addition of TEA (20 mM) to the bath
reduced the instantaneous current (C) and the ‘‘TEA-resistant’’ current
was further reduced by addition of 5 mM 4-AP (D). 4-AP-sensitive
outward K
+ currents (IA) were obtained by subtraction of the outward
K
+ currents shown in D from the outward K
+ currents illustrated in C (E).
F depicts the I–V curves as indicated. G illustrates the normalized peak
outward K
+ currents taken at +60 mV showing that TEA produced
approximately 17% of reduction of peak outward K
+ currents while 4-AP
yielded about 58% of reduction. Values are presented as the mean
6 SEM, n=8. **p,0.01, ***p,0.001, ### p,0.001.
doi:10.1371/journal.pone.0025994.g001
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Recently, PKC activation was shown to be involved in increasing
IA and neuronal apoptosis in rat cerebellar granule neurons [27].
In order to determine whether gp120 increases IA through
activation of PKC, we used phorbol myristate acetate (PMA) to
mimic DAG activation of PKC and GF109203X as a PKC
inhibitor. Figure 5 shows brief incubation of rat cortical neurons
with PMA produced an increase of IA similar to those produced by
gp120, with an average current density of 94.465.2 pA/pF
(n=49). The difference is statistically significant (p,0.01) when
compared to the average current density of 78.762.6 pA/pF
(n=128) recorded in control neurons, indicating an increase
neuronal IA via PKC. The involvement of PKC signaling in
gp120-mediated enhancement of neuronal IA was demonstrated
by experimental results showing that co-incubation of cortical
neurons with gp120 and PKC inhibitor GF109203X significantly
(p,0.01) attenuated gp120-associated increase of IA. The average
current densities recorded in the absence and presence of
GF109203X were 89.263.4 pA/pF (n=115) and 75.263.7 pA/
pF (n=57), respectively.
Inhibition of gp120-induced apoptosis by 4-AP and T140
Activation of Kv channel has been considered an essential
pathway in programmed cell death [21]. To investigate whether
the gp120-mediated enhancement of IA contributes to gp120-
induced neuronal injury, we examined the protective effects of 4-
AP on gp120-induced neuronal apoptosis in rat cortical neuronal
cultures. Cell nuclei were labeled with DAPI staining (blue) and
apoptotic cells were determined by TUNEL staining (green) of
fragmented DNA (Fig. 6A). Visualized by TUNEL staining,
incubation of neuronal cultures with gp120 for 24 h resulted in
neuronal apoptosis in a dose-dependent manner as shown in
Fig. 6B. At the concentrations of 200 pM and 500 pM, the
percentages of apoptotic neurons induced by gp120 were
23.463.6% and 29.362.8% (n=4, each in triplicate, the same
in the followings of this section), respectively, compared to
Figure 2. Enhancement of IA by gp120. A shows representative current traces recorded in control (Ctrl, left) and gp120-treated (gp120, right) rat
cortical neurons in the presence of TEA (20 mM, upper) and 4-AP (5 mM, lower). The voltage protocol utilized to generate outward K
+ currents were
the same as shown in Fig. 1A. Note that gp120 enhanced IA (upper) with no apparent effect on delayed rectifier like IK (lower). B is a summarized bar
graph illustrating gp120 enhancement of the IA, but not the IK. Each value represents the mean 6 SEM. * p,0.05; gp120 (n=115) vs Ctrl (n=128) for
IA. p.0.05; gp120 (n=35) vs Ctrl (n=30) for IK.
doi:10.1371/journal.pone.0025994.g002
Figure 3. gp120 increased neuronal IA in a dose-dependent manner. Panel A illustrates the I–V plots of IA current densities in the absent and
present of gp120 at different concentrations indicated. * p,0.05, ** p,0.01, gp120 200 pM (n=115), 400 pM (n=63), 800 pM (n=57) vs Ctrl
(n=128), respectively. Panel B is a bar graph showing the average percentage of gp120-induced increase of neuronal IA when the instantaneous peak
currents generated in response to +60 mV voltage step were measured. ** p,0.01 as indicated.
doi:10.1371/journal.pone.0025994.g003
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difference was statistically significant (Fig. 6), demonstrating gp120
induces neuronal apoptosis in primary rat neuronal cultures. The
gp120-induced neuronal apoptosis was partially blocked either by
4-AP or the CXCR4 antagonist T140 (Fig. 6). In one subset of
cortical neuronal cultures co-incubated with 4-AP (5.0 mM) and
gp120 (200 pM or 500 pM), the average percentages of apoptotic
neurons were 9.360.9% and 13.862.5%, respectively. In
comparison with the average percentage of apoptotic neurons
observed in neuronal cultures incubated with gp120 alone, the
differences were statistically significant (Fig. 6, p,0.01, n=4),
indicating that involvement of IA in gp120-induced neuronal
Figure 4. gp120 increases neuronal IA via CXCR4. A, Representative IA current traces recorded in the presence of 20 mM TEA from a control
neuron (Ctrl) and neurons incubated with 200 pM gp120 (gp120), gp120+T140 (gp120+T140) and 50 nM T140 (T140), respectively. B, Bar graph
showing the average instantaneous peak current amplitude (% of control) generated by a voltage step from 260 mV to 60 mV. Note gp120
produced a significant increase of peak IA and this increase was blocked by T140, a CXCR4 receptor antagonist, indicating gp120 increase of neuronal
IA via CXCR4. * p,0.05, gp210 (n=115) vs Ctrl (n=128); # p,0.05, gp120 (n=115) vs gp120+T140 (n=70).
doi:10.1371/journal.pone.0025994.g004
Figure 5. Involvement of PKC in gp120-mediated enhancement of neuronal IA. A, IA currents recorded in the presence of 20 mM TEA from
a control neuron and neurons incubated with gp120 (200 pM), gp120+GF109203X (5 mM, a PKC inhibitor), and GF109203X(5 mM), respectively. B I–V
curves illustrating IA current densities generated by voltage steps in control neurons (n=128) and neurons treated with gp120 (n=115),
gp120+GF109203X (n=57) and GF109203X alone (n=55). * p,0.05, ** p,0.01, gp120 vs Ctrl; ## p,0.01, gp120+GF109203X vs gp120. C is a bar
graph plotting the average peak IA currents (% of ctrl) measured at +60 mV. Note that gp120 enhanced neuronal IA and this enhancement was
blocked by a specific PKC inhibitor GF109203X. Incubation of cortical neurons with PMA, a PKC activator (100 nM, n=49), for 30 min also produced a
significant enhancement of neuronal IA, suggesting that PKC pathway is involved in gp120-mediated enhancement of neuronal IA.* *p,0.01 and
## p,0.01 for comparisons as indicated.
doi:10.1371/journal.pone.0025994.g005
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incubated with T140 (50 nM) and gp120 (200 pM or 500 pM),
the average percentage of apoptotic neurons was significantly
(p,0.01, n=4) decreased to 7.061.2% and 12.463.1% (Fig. 6),
respectively, further supporting our aforementioned findings that
gp120 enhances neuronal IA via CXCR4.
Blockade of IA inhibits gp120-induced caspase-3
activation
It has been shown that gp120 induces neuronal injury via
activation of caspase-3 [13,19,40]. Our TUNEL results revealed
that gp120 enhancement of IA underlies gp120-induced neuronal
apoptosis as blocking IA decreased gp120-associated neuronal
apoptosis. We further investigated if caspase-3 is the downstream
pathway of gp120 enhancement of IA in rat cortical neurons.
Caspase-3 was detected with anti-caspase 3 staining (green) and
neurons were marked with anti-NeuN staining (red). Neuronal
cultures incubated with gp120 for 24 h exhibited a robust caspase-
3 activation (Fig. 7A) with an average fluorescence density of
127.466.6% of non-gp120-treated control (p,0.001). This gp120-
associated increase of caspase-3 fluorescence was significantly
reduced by addition of 4-AP (5.0 mM) to the incubation media,
with an average of 101.264.7% (Fig. 7B). These results suggest
that gp120-mediated enhancement of IA may cause caspase-3
activation and consequent neuronal apoptosis.
Discussion
The mechanisms underlying HAND pathogenesis are at present
incompletely understood. Over the years, the neurotoxicity of the
viral protein gp120 has been established and several mechanisms
proposed including N-methyl-D-aspartic acid (NMDA) receptor-
mediated excitotoxicity and CXCR4 signaling [8]. To our
knowledge, no work has been undertaken to connect gp120
toxicity to the excessive efflux of K
+ necessary for apoptosis to
occur. The critical finding of this study is the ability of gp120 to
increase outward K
+ currents in cultured rat cortical neurons.
More specifically, the peak amplitude of IA was increased in a
dose-dependent manner and could be blocked, along with gp120-
induced apoptosis, by simultaneous treatment of gp120-incubated
cortical neurons with the Kv channel blocker 4-AP.
Several pieces of additional data collected point towards a
possible mechanism. First, the CXCR4 inhibitor T140 was able to
block both gp120-mediated increases in IA and apoptosis. Given
the accumulation of research demonstrating a role for CXCR4
signaling in gp120 apoptosis [17,41], the effects on apoptosis are
perhaps unsurprising. To our knowledge, however, this is the first
work demonstrating outward K
+ currents can be increased
through CXCR4 signaling. Combined with ample research having
established a critical role for Kv channel in initiating and
sustaining apoptosis [22,25], these results may perhaps indicate a
toxic mechanism of gp120 that has thus far been unappreciated. It
should be noted that while many of the experiments regarding
apoptotic K
+ current have focused on sustained delayed rectifier
currents, there have been other reports of 4-AP-sensitive outward
K
+ currents contributing to apoptosis [26,42,43]. In any case, it
is the chronic efflux and intracellular depletion of K
+ that is
necessary for apoptosis, which in pathological conditions could
occur via IA. Our finding that gp120 increases IA and that 4-AP
blocks gp120-induced apoptosis stands as evidence of this
possibility. Since our evidence indicates this occurs via the G-
protein coupled CXCR4 receptors, we next attempted to identify
an intracellular signaling cascade, such as PKC, that could be
responsible for this pathological increase in IA.
In general, PKC activation occurs through G-protein coupled
receptors, which when signaled activate phospholipase C (PLC) to
hydrolyze phosphatidylinositol-4,5-bisphosphate (PIP2) to DAG
[38,44]. PKC isozymes can be categorized according to the
combination of phosphatylserine (PS), DAG, and Ca
2+ required
for activation as conventional (PS, DAG, and Ca
2+), novel (PS and
DAG), or atypical (PS) [44]. In this experiment, we used the
phorbol ester PMA to mimic DAG activation of conventional and
novel isozymes. We found this activation of PKC to mimic gp120
increases in IA. However, precision targeting of PKC isoforms has
revealed that, in general, conventional isoforms (such as PKCa)
have anti-apoptotic roles while novel isoforms (such as PKCd)
have pro-apoptotic roles [37,39]. The relative expression of
different PKC isozymes also varies with tissue, subcellular
localization, and even between neuronal compartments [38],
complicating the situation. Therefore, while PKC activation has
been shown elsewhere to decrease Kv channel current [45,46,47]
and in some cases has neuroprotective effects [48,49], PKC
activators have been shown to induce apoptosis in many cell types
Figure 6. Attenuation of gp120-induced neuronal apoptosis by T140 or 4-AP. A shows immunocytochemical analysis of apoptosis (TUNEL
staining) in cortical neuronal cultures induced by gp120 (200 pM) in the absence and presence of T140 (50 nM) or 4-AP (5 mM). Intact cell nuclei were
visualized with DAPI staining (blue) of nucleic acids and apoptotic cells were labeled with TUNEL staining (green) of fragmented DNA (magnification
640). B is a bar graph illustrating the percentage of TUNEL positive cells in response to gp120, T140 and 4-AP and showing that cultures incubated
with gp120 for 24 h exhibited a significant increase of apoptotic neurons and that application of T140 or 4-AP significantly attenuated the gp120-
induced increase of neuronal apoptosis. 12 randomly selected visual fields were counted in each group ** p,0.01, *** p,0.01. a; 200 pM; b; 500 pM.
doi:10.1371/journal.pone.0025994.g006
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or mutation of apoptotic PKC isozymes in many cases attenuates
this apoptosis [50,54,55,56]. Under our experimental conditions,
the apoptotic effects of brief exposure to PMA were confirmed by
assay of reactive oxygen species (data not shown). Furthermore,
PKC inhibition using GF109203X was protective against gp120-
mediated apoptosis. While not definitive, these experiments lay the
groundwork for understanding the intracellular signals involved
in apoptotic gp120 increases in IA and indicate a possible role of
apoptotic PKC pathways.
With our other mechanistic studies, the emerging picture
indicates a possible scenario whereby gp120 affects apoptosis
through G-protein-coupled CXCR4 receptor signaling and
activates apoptotic PKC–caspase-3 pathways. Overall, the finding
that gp120 mediates enhancement of IA could have relevance at
several levels within the context of HAND. The first and most
obvious biological significance is the contribution of enhancement
of IA to gp120-induced apoptosis. Current consensus holds that
HIV-infected and activated macrophages migrate across a
weakened blood-brain barrier and secrete soluble viral proteins
in addition to cellular factors that lead to direct or indirect
neuronal damage [8]. Of these viral proteins, substantial evidence
has implicated gp120 in the neurotoxic brain pathology underly-
ing HAND [10,13,15]. Gp120-induced neuronal damage has been
linked to NMDA receptor excitotoxicity and CXCR4 receptor [8];
however, until now, the involvement of K
+ homeostasis in the
apoptotic process [20,21,23] in association with HIV-1-associated
neurodegeneration has largely been unappreciated. Bringing
together these two avenues of research may help complete the
mechanism of gp120-induced neurotoxicity and HAND neuropa-
thology.
Secondly, cognitive decline in HAND may result as much from
neuronal dysfunction as from neuronal loss, an idea supported by
experimental results showing alterations in cell layer volume [57]
and dendritic morphology [4] correlate with HAD [58]. Indeed,
extensive cell death is not always present when symptoms manifest
[59] and antiretroviral therapy (ART) treatment has been known
to lead to cognitive improvement [60,61,62,63], suggesting the
underlying pathology of HAD may be in part reversible. This is
consistent with a channelopathy hypothesis originally described by
Dr. Ben Gelman [64], which led our laboratory to investigate Kv
channel involvement in HAND [65]. Kv channels are well known
to regulate membrane potential and thereby the repolarization,
discharge frequency, and waveforms of action potentials (AP). Due
to a negative equilibrium potential relative to the AP threshold,
outward K
+ currents are essentially inhibitory. Not surprisingly,
decreased outward K
+ currents have been found to correspond
with improved memory and long-term potentiation (LTP), while
increased outward K
+ currents correspond to learning and
memory deficiencies [65]. Continuing research involving outward
K
+ currents has given broad support to this general concept.
Whether dendritic, somatic, axonal, or terminal, Kv 1.1 (with b
subunit), Kv 1.4, or Kv 4, appropriate A-type current has been
shown to be crucial for LTP induction, learning and memory,
axonal signal propagation, and terminal transmitter release [65].
Therefore, increased outward K
+ currents could be expected to
have a deleterious effect on neuronal function with subsequent
induction of apoptosis. In previous experiments, we found
injection of HIV-infected macrophages into severe combined
immune deficient (SCID) mice basal ganglia inhibits LTP and
impairs radial arm water maze performance, measures of learning
and memory that were restored with systematic administration of
the Kv channel blocker 4-AP [66]. The present research more
Figure 7. Activation of caspase-3 is involved in gp120 enhancement of neuronal IA and resultant neuronal apoptosis. A,
Photomicrograph of neuronal cultures treated with gp120 in the absence or presence of T140 or 4-AP. Caspase-3 was labeled with anti-caspase-3
antibody (green) and nuclei were labeled with NeuN (red). Note that gp120 increased the caspase-3 positive cells and this increase was attenuated by
either T140 or 4-AP. Twelve different areas were measured in each group, and the experiments were done in triplicates (magnification640). B, A bar
graph illustrates the average fluorescence density of caspase-3 detected in different experimental conditions. The fluorescence intensity in the
control (Ctrl) group was normalized as 100%. *** p,0.001.
doi:10.1371/journal.pone.0025994.g007
Figure 8. A schematic diagram illustrating the potential
pathways for gp120 enhancement of neuronal IA and resultant
neuronal apoptosis.
doi:10.1371/journal.pone.0025994.g008
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underlying mechanism of neuronal dysfunction and eventual cell
death in HAND.
While gp120 is supposed to increase IA by direct action on
neurons, it should be noted that 5–10% of the cells present in
culture are glia. Gp120 can also interact with glia and promote the
release of immunological factors [67,68] that could also potentially
alter outward K
+ currents [65]. Previous experiments in our
laboratory have demonstrated that conditioned media recovered
from immune-activated macrophages increase neuronal outward
K
+ currents and induce neuronal apoptosis [69] suggesting the
gp120 increases of neuronal outward K
+ currents may be in some
part attributable to indirect activation of bystanders such as glial
cells and resultant production of soluble substances. This issue is
significant in the sense of understanding the precise mechanism of
gp120-induced increases in IA and apoptosis. However, the key
finding here remains that gp120 does indeed induce enhancement
of neuronal outward K
+ currents and apoptosis, which can be
attenuated by Kv channel blocker 4-AP. While many questions still
exist, knowledge of Kv channel dysfunction induced by gp120 and
other soluble factors can serve as a starting point for developing
adjunctive therapies to target the disrupted neuronal function in
HAND.
In summary, the experimental data provide in vitro evidence that
the HIV-1gp120 increases IA via CXCR4-PKC pathway leading
to neuronal apoptosis. The enhancement of IA resulted in
neuronal apoptosis by activation of caspase-3 (Fig. 8) and the
gp120-induced neuronal apoptosis was significantly attenuated by
4-AP, a Kv channel antagonist. These results suggest that Kv
channels are involved in HIV-1-associated neuropathogenesis.
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